Home / US / The university says a professor stole a student's invention and sold it

The university says a professor stole a student's invention and sold it



The lawsuit filed this week says Ashim Mitra has taken a "groundbreaking" drug formulation to the student and could win up to $ 10 million in royalties.

Mitra, who resigned from university, denied the allegations to CNN.

The lawsuit also mentions Mitra's wife, who worked in her husband's lab, and two drug companies using the invention.

The university claims that Mitra has secretly worked with the companies to develop the patent. This describes an innovative way of delivering drugs to the eye through nanotechnology.

The drug was recently approved by the FDA, the university said. It is a treatment for the dry eye, a common disease in the elderly.

The University's Claim

In a statement to CNN, the University said:

"Mitra UMKC's own inventions stolen, sold to industry, these companies Supporting patenting and commercialization, denying credit to a deserving student and harvesting a personal financial accident ̵

1; concealed his efforts and denied his involvement. "

The lawsuit seeks to designate student Kishore Cholkar as the legitimate inventor of the patent based on his research in 2010.

The University Directive states that it has the rights to discoveries that employees and students made while working at the university. When commercial rewards are harvested, the inventor is entitled to one-third of the profit, and the school keeps the remaining two-thirds, the school said.

The reaction of the professor

19659002] On Thursday, by phone, the professor denied the allegations and told CNN that Cholkar does not deserve the patent.

"Everyone is trying to jump and get a piece of the pie," he said. Mitra

He added that he was consulting with his lawyers on how best to handle the lawsuit.

Cholkar's work involved a portion of the eye unaffected by the drug, said Mitra

.

Student Cholkar is now working for a California-based pharmaceutical company. CNN has turned to Cholkar for comment.

Marlena Baldacci of CNN contributed to this report.


Source link